Jasper Therapeutics Inc (JSPR)
Healthcare
Biotechnology
0.63 $
+1.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Jasper Therapeutics Inc (JSPR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -15 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13 | -12 | -16 | -16 | -12 | -14 | -21 | -23 | -15 | -17 | -22 | -15 | -69 | |
| 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.5 | 0.2 | 0.3 | 0.3 | 0.2 | 0.3 | 0.0 | 0.8 | |
| 1.4 | 1.4 | 1.2 | 1.2 | 1.5 | 2.0 | 2.0 | 1.8 | 1.8 | 1.4 | 1.7 | 0.4 | 5.3 | |
| 1.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.5 | 4.1 | -1.4 | -3.6 | 1.0 | 1.9 | 0.8 | -3.9 | 8.9 | -0.2 | -9.7 | -4.4 | -5.4 | |
| 0.0 | 0.0 | 0.2 | 0.0 | 0.2 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | – | -0.2 | 0.0 | -0.2 | -0.3 | -0.1 | 0.0 | 0.0 | 0.1 | 0.1 | – | – | |
| 0.0 | – | 0.0 | – | – | 0.0 | 0.3 | – | 0.2 | – | -0.2 | – | – | |
| -0.3 | 0.0 | -0.3 | 47 | 0.2 | 0.0 | 0.3 | 0.0 | 6.2 | 28 | -0.3 | – | – | |
| -14 | -12 | -17 | 32 | -12 | -14 | -21 | -23 | -9.3 | 11 | -22 | -15 | -35 | |
| -13 | -12 | -17 | -16 | -12 | -14 | -21 | -23 | -15 | -17 | -22 | -15 | -69 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.